DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Amphetamine (Amphetamine) - Summary

 

-- advertisement --

AMPHETAMINE SUMMARY

A single entity amphetamine product combining the neutral sulfate salts of dextroamphetamine and amphetamine, with the dextro isomer of amphetamine saccharate and d, l-amphetamine aspartate.

Attention Deficit Disorder with Hyperactivity: Adderall is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted.

AMPHETAMINE NEWS HIGHLIGHTS

Media Articles Related to Amphetamine

FDA Approvals: Adderall XR for Adults, Topamax for Migraines, and Others
Source: Medscape Primary Care Headlines [2004.08.19]

more>>

Published Studies Related to Amphetamine

A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. [2008.05]

The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. [2008.04]

Bupropion for the treatment of methamphetamine dependence. [2008.04]

The explicit learning of new names for known objects is improved by dexamphetamine. [2008.03]

Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals. [2008.03]

more>>

Clinical Trials Related to Amphetamine

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories [Completed]

Dextro-Amphetamine Versus Caffeine in Treatment-Resistant OCD [Active, not recruiting]

A Pilot Study of Citicoline Add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence [Recruiting]

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse [Completed]

Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical Therapy [Completed]

more>>

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008